Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population

• Ran Huo ,

  Contributed equally to this work with: Ran Huo, Kefu Tang

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Kefu Tang ,

  Contributed equally to this work with: Ran Huo, Kefu Tang

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Zhiyun Wei,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Lu Shen,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Yuyu Xiong,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Xi Wu,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Jiamin Niu,

  Affiliation Laiwu Hospital, Shandong, People’s Republic of China

  ⨯
• Xia Han,

  Affiliation Laiwu Hospital, Shandong, People’s Republic of China

  ⨯
• Zhengan Tian,

  Affiliation Shanghai International Travel Healthcare Center, Shanghai, People’s Republic of China

  ⨯
• Lun Yang,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯
• Guoyin Feng,

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China, Shanghai Institute of Mental Health, Shanghai, People’s Republic of China

  ⨯
• Lin He ,

  * E-mail: helin@bio-x.cn (HL); chinsir@sjtu.edu.cn (SQ)

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China, Institutes of Biomedical Sciences, Fudan University, Shanghai, People’s Republic of China

  ⨯
• Shengying Qin

  * E-mail: helin@bio-x.cn (HL); chinsir@sjtu.edu.cn (SQ)

  Affiliations Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, People’s Republic of China, Shanghai Genomepilot Institutes, Shanghai, People’s Republic of China

  ⨯